iBio (IBIO) EV/FCF: History & Chart

iBio, Inc.(IBIO)

Biotechnology · San Diego, CA

$1.11-0.01 (-0.89%)

Delayed quote: Oct 6, 2026, 11:15 AM EDT

About iBio, Inc.

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, including IBIO-200 and IBIO-201, designed to prevent severe acute respiratory syndrome coronavirus 2. Another candidate, IBIO-400, is in development for the treatment of classical swine fever. Beyond its proprietary pipeline, iBio provides recombinant proteins to third parties, available both as catalog items and custom-synthesized products. It also offers comprehensive services spanning process development, advanced manufacturing, filling and finishing, and bioanalytical support. iBio maintains several strategic partnerships: a licensing agreement with Planet Biotechnology, Inc. for infectious disease therapeutics; a collaborative effort with The Texas A&M University System focused on COVID-19 vaccine candidates; a licensing pact with the University of Natural Resources and Life Sciences, Vienna; and a collaboration with CC-Pharming Ltd. Its corporate headquarters are situated in Bryan, Texas.

San Diego, CA

23 employees

www.ibioinc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martin Brenner

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
iBio, Inc. (IBIO)	$71.38M	N/A	N/A	N/A	N/A
MindWalk Holdings Corp. (HYFT)vs ›	$70.95M	N/A	1223.62x	1223.62x	1223.62x
Fortress Biotech, Inc. (FBIO)vs ›	$68.42M	N/A	N/A	N/A	N/A
Champions Oncology, Inc. (CSBR)vs ›	$68.08M	N/A	16.52x	23.77x	35.86x
Gain Therapeutics, Inc. (GANX)vs ›	$74.00M	N/A	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$65.93M	N/A	54.90x	54.90x	54.90x
Cingulate Inc. (CING)vs ›	$65.41M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$65.19M	N/A	1.41x	1.41x	1.41x
InterCure Ltd. (INCR)vs ›	$64.68M	14.63x	12.61x	12.61x	118.68x
Hyperfine, Inc. (HYPR)vs ›	$76.11M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/FCF RATIO

TTM

iBio, Inc. (IBIO)

$71.38M

N/A

MindWalk Holdings Corp. (HYFT)vs ›

$70.95M

N/A

1223.62x

Fortress Biotech, Inc. (FBIO)vs ›